Profile
Martin Brusdeilins worked as the Chief Scientific Officer & Executive VP at Tecan Group AG from 2014 to 2014.
Prior to that, he was the VP-Product Development, Research & Development at Ortho-Clinical Diagnostics, Inc. from 2003 to 2011.
Brusdeilins holds a doctorate degree from Eberhard Karls Universität Tübingen.
Former positions of Martin Brusdeilins
| Companies | Position | End |
|---|---|---|
| TECAN GROUP AG | Chief Operating Officer | 13/07/2014 |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Chief Tech/Sci/R&D Officer | 31/12/2010 |
Training of Martin Brusdeilins
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TECAN GROUP AG | Health Technology |
| Private companies | 1 |
|---|---|
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
- Stock Market
- Insiders
- Martin Brusdeilins
